Tuesday, 2nd September Australasian RNA Biology and Biotechnology Association 2025 Conference

• RNA for Rare Disease (RNA4RD): revolutionising rare disease diagnosis with RNA testing - Sandra Cooper
• The long and the short of it: the role of noncoding RNAs in the response to targeted therapy - Glen Reid
• UPF1 variants cause intellectual disability via mechanisms convergent with fragile X syndrome - Lachlan Jolly
• PUS7-mediated pseudouridylation drives vincristine resistance in B-cell acute lymphoblastic leukaemia through epitranscriptomic reprogramming    - Agin Ravindran

• Life in Flux: Dynamic RNA:Protein Complex Assembly Shapes Biomolecular Function - Nils G Walter
• Edi-Set-Flow: A best practices pipeline for RNA editing detection and differential analysis in bulk RNA-seq - Jacob E Munro
• Viral structurome and epitranscriptome as therapeutic targets - Vincent Corbin

• A Role for the RNA Modification m⁶A at the Virus-Host Interface - Stacy Horner
• The innate immune sensor MDA5 guards against infection by surveying cellular RNA homeostasis - Natalia G Sampaio
• An mRNA reporter construct for simultaneous assessment of lipid nanoparticle immunogenicity and vaccine expression in vivo - Elizabeth Chan
• Dual RNA-interactome capture isolates a bacterial toxin that targets host messenger RNA during infection. - Kitty McCaffrey

• TERRA RNA in cancer and aging - Hsueh-Ping HC Chu
• Decoding a Pan-Cancer LncRNA: From Mechanisms to Therapeutic Potential - Yuchen Feng
• Development of a potential lncRNA therapeutic for ER+ breast cancer - Stacey L Edwards
• Computational Discovery of TDP-43-Responsive Circular RNA:DNA Hybrids (circR-loops) in Neuronal Cells - Sayanthooran Saravanabavan

• Uncovering the functions of alternative splicing using novel RNA-targeting CRISPR technology - Jasleen Rajpal
• Comparative evaluation of mRNA lipid nanoparticles and recombinant proteins for monoclonal antibody delivery against COVID-19 and influenza - Mai N. Vu
• ScIsoX: A Multidimensional Framework for Measuring Isoform-Level Transcriptomic Complexity in Single Cells - Ulf Schmitz
• Exploring the role of miRNAs and their target transcription factors in the development of Neuroblastoma. - Fakhira H Nazki
• Targeting oncogenic long non-coding RNAs in colorectal cancer-associated macrophages - Brooke K Morrison
• Nanopore direct RNA sequencing reveals transcriptome and epitranscriptome regulation by long non-coding RNAs in childhood acute lymphoblastic leukemia  - Qing Wang
• RNA binding, but not editing, by ADAR1p150 regulates haematopoietic homeostasis. - Carl Walkley
• INDEGRA: Transforming RNA quantification accuracy through degradation-aware read reallocation for direct nanopore sequencing - Nikolay Shirokikh
• Ion pairing-free mass spectrometry analysis of RNA oligonucleotides: the quantification of mRNA capping efficiency and CRISPR/Cas13 cleavage as case studies - Enzo Huang
• A novel long noncoding RNA responsible for genetic susceptibility to breast cancer - Juliet D French
• The TREX-2 complex functions as an independent mRNA export receptor. - Yoona Kim
• Not a me too, a first to market. - Peter Davis
• Quantification of bulk RNA modifications in yeast and human cells using mass spectrometry - Vita Levina
• Selective loss of Neanderthal alleles in haplotype blocks associated with cognition in modern humans - Mitchell J Cummins
• Limitations of SELECT in CRISPR dCas13-based m⁶A Editing Detection and a High-Resolution Alternative - Majid Mehravar
• Investigating bromoform biosynthesis in the red seaweed Asparagopsis taxiformis using a combined mRNA-seq and miRNA-seq approach - Jessica Webb
• Identification of exacerbation-specific long non-coding RNA signatures of children with wheeze and asthma - Ashlyn Poole
• Development of Neuroblastoma Targeted siRNA Therapeutics using Dependency Gene Mapping - Amy Logan
• Identification and Functional Characterization of RCMT9, a Novel RNA m⁵C Methyltransferase in Arabidopsis thaliana - Jasjyot Singh Khanduja
• A chimeric viral platform for directed evolution in mammalian cells - Christopher E Denes
• The ataxin-3 protein regulates RNA-binding proteins in neurodegenerative diseases - Anastasiya Potapenko
• TREX complex subunit variation leads to adverse neurodevelopmental outcomes - Raman Sharma
• Cut to the point: m⁶A facilitates 3’ end mRNA processing in Plasmodium falciparum - Joshua M Levendis
• New Zealand’s RNA Platform: Research, Development, and Updates - Joanna Kuang
• Discovery and characterisation of seekRNA/bridgeRNA – programmable RNA-guided large scale DNA insertion technology - Rezwan R.S Siddiquee
• Highly conserved siRNAs encapsulated in LNPs protect against SARS-CoV-2 - Yuan Zhang
• Targeting Nsp9 with modified hairpin RNAs for potential antiviral leads - Esther Zhang
• Deep learning-guided drug target selection: towards discovery of modulators of RNA-binding proteins - Jameel M. Abduljalil
• Targeting the untargetables: inhibiting RNA-binding proteins with nucleic acid mimics - Ann Kwan
• Engineering mRNA for Improved Longevity and Protein Expression - Tessa Swain
• Evolutionary Conservation and Functional Implications of m⁶A mRNA Modifications Across Mammals - Favour Oyelami
• High-throughput Isolation and Characterisation of Human Intergenic MicroRNA Promoters - Kara Henry-Cocks
• Promote targeted shRNA locks HIV-1 latency via repressive epigenetic modifications: A Block and Lock therapeutic strategy - Andleeb Hanif
• Rapid, Reversible Shape-Shifting and Division in Giant Vesicle - Rabia Ali

7:00pm - 10:00pm
The Old Clare Hotel, Toch Bar